Dry Eye Colloquium: Improving Diagnosis, Treatment, and Patient Outcomes

This activity is supported by unrestricted educational grants from Alcon, Bausch & Lomb, BioTissue, Johnson and Johnson, Kala Pharmaceuticals, and Sun Pharmaceuticals.

Speakers:

Doug Devries, OD and Marc Bloomenstein, OD

Release Date:

February 11, 2021

Expiration Date:

January 21, 2024

Estimated time to complete activity:

4 hours

Computer System Requirements:

Access to internet and a web browser is required to complete this activity.

Goal Statement:

This course will provide a comprehensive overview of dry eye diagnosis, treatment, and patient management.

Educational Objectives:

After completing this activity, the participant should be better able to:

  1. Outline traditional and new diagnostic techniques for dry eye and Meibomian gland dysfunction.
  2. Appreciate the role of Meibomian gland dysfunction in dry eye.
  3. Consider the diverse array of dry eye disease therapies and approaches to effective patient management.
  4. Describe the mechanisms of action for therapies that directly address tear film physiology and gland function.

Target Audience:

This activity is intended for optometrists who provide primary care optometry services, including but not limited to medical optometric services.

Faculty/Editorial Board:

Doug Devries, OD
Marc Bloomenstein, OD

Continuing Education Credit: 

This activity, COPE Activity Number 121012 is accredited by COPE for continuing education for optometrists. This course is COPE approved for 4 hours of CE credit. Course ID is 70852-AS. Please check your state licensing board to see if this approval counts toward your CE requirement for relicensure.

Reviewed by

Disclosure of Conflicts of Interest:

Review Education Group (REG) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to REG policy. REG is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.


Douglas Devries, OD

Fees for Non-CME/CE services from Allergan, Alcon, Johnson and Johnson Vision, BioTissue, Ivantis, RySurg, Sun, Kala, Oyster Point, TearLab, Bausch Health, Bruder, BVI Medical, Shire (Takeda), OcuSoft, EyeVance

Ownership interest in Quidel

Marc Bloomenstein, OD, FAAO

Consulting fees from Reichert, Takeda, Johnson & Johnson, Sun, BioTissue, Allergan, Bausch & Lomb, Novartis, Kala, Eyevance

Fees for Non-CME/CE services from Allergan, Bausch & Lomb

Planners and Managers
REG planners and managers have nothing to disclose.

Method of Participation Request for Credit:

During the period February 11, 2021 through January 21, 2024 participants must read the learning objectives, faculty disclosures and view the complete educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation at the conclusion of this course.  Post course tests must receive a score of 70% or better in order for a certificate of completion to be issued.

Media:

Video

Disclosure of Unlabeled Use:

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer:

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.  Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Watch this online video course and click the link below to take the exam for 4 hours of CE credit.